BrightPath Biotherapeutics Co., Ltd. (TYO:4594)

TYO:4594 Statistics

Total Valuation

TYO:4594 has a market cap or net worth of JPY 7.68 billion. The enterprise value is 6.43 billion.

Market Cap	7.68B
Enterprise Value	6.43B

Important Dates

The next estimated earnings date is Friday, February 13, 2026.

Earnings Date	Feb 13, 2026
Ex-Dividend Date	n/a

Share Statistics

TYO:4594 has 112.97 million shares outstanding. The number of shares has increased by 127.19% in one year.

Current Share Class	112.97M
Shares Outstanding	112.97M
Shares Change (YoY)	+127.19%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	2.52%
Owned by Institutions (%)	-2.57%
Float	108.91M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6,920.48
PB Ratio	5.03
P/TBV Ratio	5.03
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-5.98
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.86

Financial Position

The company has a current ratio of 15.75

Current Ratio	15.75
Quick Ratio	11.98
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-67.97%
Weighted Average Cost of Capital (WACC)	13.27%
Revenue Per Employee	26,429
Profits Per Employee	-25.60M
Employee Count	42
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, TYO:4594 has paid 2.16 million in taxes.

Income Tax	2.16M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +58.14% in the last 52 weeks. The beta is 1.64, so TYO:4594's price volatility has been higher than the market average.

Beta (5Y)	1.64
52-Week Price Change	+58.14%
50-Day Moving Average	55.86
200-Day Moving Average	58.95
Relative Strength Index (RSI)	59.34
Average Volume (20 Days)	9,085,295

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TYO:4594 had revenue of JPY 1.11 million and -1.08 billion in losses. Loss per share was -11.35.

Revenue	1.11M
Gross Profit	1.08M
Operating Income	-1.08B
Pretax Income	-1.07B
Net Income	-1.08B
EBITDA	n/a
EBIT	-1.08B
Loss Per Share	-11.35

Balance Sheet

The company has 1.25 billion in cash and n/a in debt, with a net cash position of 1.25 billion or 11.09 per share.

Cash & Cash Equivalents	1.25B
Total Debt	n/a
Net Cash	1.25B
Net Cash Per Share	11.09
Equity (Book Value)	1.53B
Book Value Per Share	13.70
Working Capital	1.54B

Cash Flow

In the last 12 months, operating cash flow was -1.32 billion and capital expenditures -1.96 million, giving a free cash flow of -1.32 billion.

Operating Cash Flow	-1.32B
Capital Expenditures	-1.96M
Free Cash Flow	-1.32B
FCF Per Share	-11.71

Margins

Gross Margin	97.66%
Operating Margin	-97,561.62%
Pretax Margin	-96,665.77%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TYO:4594 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-127.19%
Shareholder Yield	-127.19%
Earnings Yield	-14.00%
FCF Yield	-17.22%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TYO:4594 has an Altman Z-Score of 11.52 and a Piotroski F-Score of 1.

Altman Z-Score	11.52
Piotroski F-Score	1